GE HealthCare Technologies Inc. $GEHC Holdings Decreased by Kennedy Capital Management LLC

Kennedy Capital Management LLC reduced its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 108,429 shares of the company’s stock after selling 7,182 shares during the period. Kennedy Capital Management LLC’s holdings in GE HealthCare Technologies were worth $8,031,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in GEHC. Guggenheim Capital LLC raised its holdings in shares of GE HealthCare Technologies by 22.3% during the second quarter. Guggenheim Capital LLC now owns 131,985 shares of the company’s stock worth $9,776,000 after purchasing an additional 24,087 shares during the period. CW Advisors LLC grew its position in shares of GE HealthCare Technologies by 5.6% during the 2nd quarter. CW Advisors LLC now owns 10,297 shares of the company’s stock valued at $763,000 after buying an additional 547 shares during the last quarter. Locust Wood Capital Advisers LLC grew its position in shares of GE HealthCare Technologies by 11.6% during the 2nd quarter. Locust Wood Capital Advisers LLC now owns 1,946,345 shares of the company’s stock valued at $144,166,000 after buying an additional 202,027 shares during the last quarter. Beacon Pointe Advisors LLC raised its stake in GE HealthCare Technologies by 4.3% during the second quarter. Beacon Pointe Advisors LLC now owns 11,479 shares of the company’s stock worth $850,000 after acquiring an additional 472 shares during the period. Finally, Wellspring Financial Advisors LLC bought a new position in GE HealthCare Technologies in the second quarter worth about $205,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of analyst reports. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. BTIG Research restated a “buy” rating and set a $87.00 price target on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Stifel Nicolaus set a $90.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a research note on Monday. Finally, Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $86.45.

GE HealthCare Technologies Price Performance

GEHC stock opened at $82.52 on Friday. The firm has a 50-day moving average of $75.69 and a two-hundred day moving average of $74.39. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $37.59 billion, a PE ratio of 17.05, a P/E/G ratio of 3.49 and a beta of 1.10.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.